20 LATEST RESOURCES (598 INDEXED)
×
Pilot RCT Comparing Low-Dose Naltrexone, Gabapentin and Placebo to Reduce Pain among People with HIV with Alcohol Problems · February 2024
Articles
PLOS ONE
×
Factors Associated with Frequent Buprenorphine / Naloxone Initiation in a National Survey of Canadian Emergency Physicians · February 2024
Articles
PLOS ONE
×
Prevalence of Current Restless Legs Syndrome Symptoms among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder · October 2023
Articles
Nature and Science of Sleep
×
Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series · August 2023
Articles
Cureus
×
How to Save a Life: Public Awareness of a National Mass Media Take Home Naloxone Campaign, and Effects of Exposure to Campaign Components on Overdose Knowledge and Responses · August 2023
Articles
International Journal of Drug Policy
×
Association between Body Mass Index and Treatment Completion in Extended-Release Naltrexone-Treated Patients with Opioid Dependence · August 2023
Articles
Frontiers in Psychiatry
×
Naloxone Accessibility Under the State Standing Order Across Mississippi · July 2023
Articles
JAMA Network Open
×
Successful Management of Kratom Use Disorder with Buprenorphine and Naloxone · June 2023
Articles
Cureus
×
Naltrexone Plus Bupropion Combination Medication Maintenance Treatment for Binge-Eating Disorder Following Successful Acute Treatments: Randomized Double-Blind Placebo-Controlled Trial · June 2023
Articles
Psychological Medicine
×
Associations of Methadone and Buprenorphine-Naloxone Doses with Unregulated Opioid Use, Treatment Retention, and Adverse Events in Prescription-Type Opioid Use Disorders: Exploratory Analyses of the OPTIMA Study · June 2023
Articles
American Journal on Addictions
×
Low-Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions: A Scoping Review · June 2023
Articles
Pain Medicine
×
Naloxone Training and Availability in the US Commercial Fishing Industry · May 2023
Articles
American Journal of Industrial Medicine
×
Barriers and Facilitators of Naloxone and Safe Injection Facility Interventions to Reduce Opioid Drug-Related Deaths: A Qualitative Analysis · May 2023
Articles
International Journal of Drug Policy
×
Sweden’s first Take-Home Naloxone Program: Participant Characteristics, Dose Endpoints and Predictors for Overdose Reversals · April 2023
Articles
Substance Abuse Treatment, Prevention, and Policy
×
Using Naltrexone to Validate a Human Laboratory Test System to Screen New Medications for Alcoholism (TESMA)- A Randomized Clinical Trial · April 2023
Articles
Translational Psychiatry
×
Optimizing Naloxone Distribution to Prevent Opioid Overdose Fatalities: Results from Piloting the Systems Analysis and Improvement Approach within Syringe Service Programs · March 2023
Articles
BMC Health Services Research
×
The Effectiveness of a Noninterruptive Alert to Increase Prescription of Take-Home Naloxone in Emergency Departments · January 2023
Articles
Journal of the American Medical Informatics Association
×
Population Pharmacokinetics of Buprenorphine and Naloxone Sublingual Combination in Chinese Healthy Volunteers and Patients with Opioid Use Disorder: Model-Based Dose Optimization · January 2023
Articles
Frontiers in Pharmacology
×
Buprenorphine-Naloxone, Buprenorphine, and Methadone Throughout Pregnancy in Maternal Opioid Use Disorder · December 2022
Articles
Acta Obstetricia et Gynecologica Scandinavica